Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma Genetics
Studies from Goteborg University in the area of adenocarcinoma genetics described
March 30th, 2008
Research findings, 'Recurrent gene amplifications in human type I endometrial adenocarcinoma detected by fluorescence in situ hybridization,' are discussed in a new report. According to recent research published in the journal Cancer Genetics and Cytogenetics, "Determining what genes are actively involved in tumor development is important, because they may provide targets for directed therapy. Human tumors are greatly heterogeneous with respect to etiology and genetic background, which complicates the identification of common genetic aberrations." "In contrast, genetic and environmental variation can be in part controlled in experimental animals, which...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-30)
|
